FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 71 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.6%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $24,457,000 | +752.2% | 649,231 | +284.8% | 0.00% | – |
Q4 2020 | $2,870,000 | +209.3% | 168,735 | -16.8% | 0.00% | – |
Q3 2020 | $928,000 | -19.3% | 202,702 | +7.6% | 0.00% | – |
Q2 2020 | $1,150,000 | +148.4% | 188,408 | -7.7% | 0.00% | – |
Q1 2020 | $463,000 | -80.9% | 204,221 | -61.4% | 0.00% | – |
Q4 2019 | $2,429,000 | +54.5% | 529,188 | +30.4% | 0.00% | – |
Q3 2019 | $1,572,000 | -19.3% | 405,681 | +26.0% | 0.00% | – |
Q2 2019 | $1,947,000 | -40.3% | 321,907 | +32.2% | 0.00% | -100.0% |
Q1 2019 | $3,263,000 | +42.9% | 243,503 | -0.8% | 0.00% | 0.0% |
Q4 2018 | $2,284,000 | -36.3% | 245,575 | -4.7% | 0.00% | 0.0% |
Q3 2018 | $3,586,000 | -5.8% | 257,652 | +7.0% | 0.00% | 0.0% |
Q2 2018 | $3,807,000 | -37.2% | 240,789 | -31.8% | 0.00% | 0.0% |
Q1 2018 | $6,064,000 | -27.6% | 353,007 | -7.6% | 0.00% | -50.0% |
Q4 2017 | $8,374,000 | -24.8% | 382,023 | +33.9% | 0.00% | 0.0% |
Q3 2017 | $11,138,000 | +24.0% | 285,363 | -4.4% | 0.00% | 0.0% |
Q2 2017 | $8,984,000 | +119.0% | 298,395 | +162.9% | 0.00% | +100.0% |
Q1 2017 | $4,103,000 | -47.4% | 113,507 | -27.0% | 0.00% | -50.0% |
Q4 2016 | $7,793,000 | +14.4% | 155,500 | +19.8% | 0.00% | 0.0% |
Q3 2016 | $6,812,000 | +104.3% | 129,775 | +61.0% | 0.00% | +100.0% |
Q2 2016 | $3,334,000 | +55466.7% | 80,629 | +52256.5% | 0.00% | – |
Q1 2016 | $6,000 | 0.0% | 154 | 0.0% | 0.00% | – |
Q4 2015 | $6,000 | -97.0% | 154 | -99.1% | 0.00% | – |
Q3 2014 | $197,000 | – | 16,791 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|